Key facts
- reach52’s last known valuation is $2.8M (Jan 2020).
- It has raised $590K; the latest was Later Stage VC in Apr 2025.
- Notable investors include Verge Capital Management, Johnson & Johnson Services, Citrine Capital, AIP Venture Partners, Altara Ventures — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for reach52
- ·The full record, as it builds
Funding rounds
No funding rounds for reach52 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About reach52
Developer of a healthcare platform designed to deliver screening, testing, affordable medicines, and health insurance. The company's platform converts data collected by a network of local agents into impact-focused awareness, engagement, and referral health campaigns, along with healthcare technology alternatives, enabling healthcare workers to get data insights and on-the-ground learnings to monitor and optimize the performance of programs.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2017
- Employees
- 59
- Website
- reach52.com/
- Ownership
- Privately Held (backing)
reach52 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in reach52 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on reach52 in its N-PORT filings yet. We sweep new filings monthly.